Don't Let Covid-19
Weaken Your Workflow
Enabling Lifescience, Biopharma, Health Sciences & Medtech
Business Continuity During Challenging Times
In the last few weeks, the lives of people around the world has been impacted. Daily
working has got compromised, particularly with regard to business continuity. Remote
working, in the best interest of organizations & employees, is becoming a necessity.
At BioSpectrum, it is our mission to empower every person and every organization on the
planet to achieve more. Our solution, Our teams, will help every employee to continue
working in a secured and collaborative manner irrespective of location.
The BioSpectrum media Customized Live & Automated
Webinar
solutions has Virtual Events & E-Conferences
conceptualised the Online Video Interview Series
following digital offering
for you to combat these Digital Round Table
adverse situations Discussions
Online Polls & Research
Surveys
Meet with anyone, anywhere
With BioSpectrum Teams, you can host online meetings - 1:1, small and medium size teams,
host live events up to 10,000 people - with consistent experience across platforms.
Brand Awareness | Better Engagement | Thought Leadership | Lead Generation
---- We wish you safe and healthy business days ahead ----
www.biospectrumindia.com www.biospectrumasia.com
Contact: Ankit Kankar | HandHeld : +919579069369 | Email : [email protected]
When a cookie
cutter response
just won’t cut it
talk to the people with a focus
on flexibility, talk to Luina Bio.
When it comes to biomanufacturing GMP materials for Products:
use in clinical trials, many production facilities lack the • Recombinant proteins
flexibility needed to create bespoke solutions in a timely, • Live Biotherapeutics
scaled and cost effective manner. At Luina Bio we do • Bacterial vaccines
things a little differently. • Plasmid DNA
With over 20 years experience in the pharmaceutical, Services:
biotechnology and veterinary industries we know the more • Bacterial / Yeast Fermentation
we focus on each client’s specific needs and goals, the • Cell Banking
clearer their vision for the future will become. Looking for • Process Development/Scale-up
an early phase clinical biomanufacturing partner? • cGMP Manufacture of
Talk to Luina Bio to see how we can bring your drug to life.
biopharmaceutical APIs
Luina Bio: your vision is our focus. • Stability Testing
Contact: visit: luinabio.com.au | call: +61 (7) 3273 9176 | email: [email protected]
The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.
10 COVID-19 candidate Vaccines in Clinical Evaluation
The rapid spread of the novel coronavirus is a reminder of how global populations and economies are interconnected. The pandemic is integrating the global healthcare force by exposing the obvious realities that no single individual, company, or country can solve the pandemic crisis alone. Researchers are optimistically demonstrating best-in-class resources from the lab to manufacturing to advance the innovations at multiple vaccine candidates. Indeed, the global biopharma manufacturing industry is funding and expanding its capabilities for vaccine production on an ‘’at-risk basis’’ to facilitate the world’s immediate need and demand. Novel paradigms of Next-generation vaccine technology platforms are accelerating the development of “one life saving vaccine” to nullify the repulsive humanitarian and economic impact. According to the WHO, as of May 30 there are 10 vaccines under clinical evaluation which have already progressed to human trials and121 candidates are in preclinical evaluation.
Discover the best professional documents and content resources in AnyFlip Document Base.
Search